BRPI0506148A - preparação farmacêutica para o tratamento de choque - Google Patents
preparação farmacêutica para o tratamento de choqueInfo
- Publication number
- BRPI0506148A BRPI0506148A BRPI0506148-2A BRPI0506148A BRPI0506148A BR PI0506148 A BRPI0506148 A BR PI0506148A BR PI0506148 A BRPI0506148 A BR PI0506148A BR PI0506148 A BRPI0506148 A BR PI0506148A
- Authority
- BR
- Brazil
- Prior art keywords
- sub
- moiety
- peptide
- pharmaceutical preparation
- bbeta
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 238000002635 electroconvulsive therapy Methods 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 abstract 2
- 102000009123 Fibrin Human genes 0.000 abstract 1
- 108010073385 Fibrin Proteins 0.000 abstract 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- 102000008790 VE-cadherin Human genes 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 108010018828 cadherin 5 Proteins 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229950003499 fibrin Drugs 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229930195734 saturated hydrocarbon Natural products 0.000 abstract 1
- 230000035939 shock Effects 0.000 abstract 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"PREPARAçãO FARMACêUTICA PARA O TRATAMENTO DE CHOQUE". A invenção refere-se ao uso de um peptídeo da fórmula geral I, em que R~ 1~ e R~ 2~, sendo iguais ou diferentes, denotam hidrogênio, uma porção de hidrocarboneto saturado ou insaturado compreendendo de 1 a 10, em particular de 1 a 3, átomos de carbono, Z~ 1~ denota uma porção de histidina ou prolina, Z~ 2~ denota uma porção de arginina, uma porção de peptídeo ou uma porção de proteína compreendendo uma porção de arginina inicial, em particular compreendendo de 2 a 30 aminoácidos, peptídeo este que tem a propriedade biológica de emparelhar o motivo de ligação de VE-caderina indutível na cadeia B<225> (isto é, B<225>~ 15-42~) da fibrina humana, para a preparação de uma preparação farmacêutica para o tratamento de choque.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0108704A AT414097B (de) | 2004-06-25 | 2004-06-25 | Pharmazeutische zubereitung zur behandlung von schock |
| AT0004005A AT501263B1 (de) | 2005-01-13 | 2005-01-13 | Pharmazeutische zubereitung zur behandlung von schock |
| PCT/AT2005/000228 WO2006000007A1 (de) | 2004-06-25 | 2005-06-24 | Verwendung von peptiden, die aus der a alpha oder der b beta kette des humanen fibrinogens abgeleitet wurden, zur behandlung von schock |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0506148A true BRPI0506148A (pt) | 2006-10-24 |
Family
ID=35058593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0506148-2A BRPI0506148A (pt) | 2004-06-25 | 2005-06-24 | preparação farmacêutica para o tratamento de choque |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20080249006A1 (pt) |
| EP (1) | EP1691827B1 (pt) |
| JP (1) | JP2008503503A (pt) |
| AT (1) | ATE439856T1 (pt) |
| AU (1) | AU2005256121B2 (pt) |
| BR (1) | BRPI0506148A (pt) |
| CA (1) | CA2544676A1 (pt) |
| CY (1) | CY1109631T1 (pt) |
| DE (1) | DE502005007926D1 (pt) |
| DK (1) | DK1691827T3 (pt) |
| EA (1) | EA008799B1 (pt) |
| ES (1) | ES2331958T3 (pt) |
| HR (1) | HRP20090618T1 (pt) |
| IL (1) | IL173969A (pt) |
| NZ (1) | NZ545634A (pt) |
| PL (1) | PL1691827T3 (pt) |
| PT (1) | PT1691827E (pt) |
| SI (1) | SI1691827T1 (pt) |
| WO (1) | WO2006000007A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT502987A1 (de) | 2005-12-23 | 2007-07-15 | Fibrex Medical Res & Dev Gmbh | Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen |
| US20080004220A1 (en) | 2006-02-23 | 2008-01-03 | Fibrex Medical Research & Development Gmbh | Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| EP1987062B1 (en) * | 2006-02-23 | 2011-06-22 | Fibrex Medical Research & Development GmbH | Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
| WO2007095659A1 (de) * | 2006-02-23 | 2007-08-30 | Fibrex Medical Research & Development Gmbh | Peptide und peptid-derivate, herstellun derselben sowie deren verwendung zur herstellung eines therapeutisch und/oder präventiv wirkenden arzneimittels |
| EP2193370A2 (en) * | 2007-09-24 | 2010-06-09 | Fibrex Medical Research & Development GmbH | Methods of screening for compounds having anti-inflammatory activity |
| WO2009096502A1 (ja) * | 2008-01-31 | 2009-08-06 | Japan As Represented By President Of National Center Of Neurology And Psychiatry | うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断 |
| US7884074B2 (en) | 2008-05-15 | 2011-02-08 | Ikaria Development Subsidiary Two, LLC | Compounds and methods for prevention and/or treatment of inflammation using the same |
| US8088890B2 (en) * | 2008-09-26 | 2012-01-03 | Fibrex Medical Research & Development Gmbh | Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| WO2010043444A2 (en) * | 2008-10-15 | 2010-04-22 | Fibrex Medical Research & Development Gmbh | Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof |
| US12128102B2 (en) | 2016-03-08 | 2024-10-29 | Takeda Pharmaceutical Company Limited | Constrained conditionally activated binding proteins |
| IL302613B2 (en) | 2017-09-08 | 2025-04-01 | Maverick Therapeutics Inc | Binding proteins are activated under limited conditions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965107A (en) * | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
| DE19729591A1 (de) * | 1997-07-10 | 1999-02-11 | Therasorb Medizinische Systeme | Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen |
| AU2002221316A1 (en) * | 2000-12-12 | 2002-06-24 | Fibrex Medical Research & Development Gmbh | Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| ATE345788T1 (de) * | 2001-03-06 | 2006-12-15 | Dorian Bevec | Verwendung von mek hemmern zur behandlung von virusvermitteltem hämorragischem schock oder fieber |
| EP1987062B1 (en) * | 2006-02-23 | 2011-06-22 | Fibrex Medical Research & Development GmbH | Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
-
2005
- 2005-06-24 CA CA002544676A patent/CA2544676A1/en not_active Abandoned
- 2005-06-24 DK DK05752350T patent/DK1691827T3/da active
- 2005-06-24 EP EP05752350A patent/EP1691827B1/de not_active Expired - Lifetime
- 2005-06-24 HR HR20090618T patent/HRP20090618T1/hr unknown
- 2005-06-24 AT AT05752350T patent/ATE439856T1/de active
- 2005-06-24 SI SI200530842T patent/SI1691827T1/sl unknown
- 2005-06-24 BR BRPI0506148-2A patent/BRPI0506148A/pt not_active IP Right Cessation
- 2005-06-24 WO PCT/AT2005/000228 patent/WO2006000007A1/de not_active Ceased
- 2005-06-24 AU AU2005256121A patent/AU2005256121B2/en not_active Ceased
- 2005-06-24 PT PT05752350T patent/PT1691827E/pt unknown
- 2005-06-24 JP JP2007516870A patent/JP2008503503A/ja active Pending
- 2005-06-24 NZ NZ545634A patent/NZ545634A/en not_active IP Right Cessation
- 2005-06-24 PL PL05752350T patent/PL1691827T3/pl unknown
- 2005-06-24 US US10/596,103 patent/US20080249006A1/en not_active Abandoned
- 2005-06-24 EA EA200600561A patent/EA008799B1/ru not_active IP Right Cessation
- 2005-06-24 ES ES05752350T patent/ES2331958T3/es not_active Expired - Lifetime
- 2005-06-24 DE DE502005007926T patent/DE502005007926D1/de not_active Expired - Lifetime
-
2006
- 2006-02-27 IL IL173969A patent/IL173969A/en not_active IP Right Cessation
-
2009
- 2009-11-13 CY CY20091101198T patent/CY1109631T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL173969A0 (en) | 2006-07-05 |
| JP2008503503A (ja) | 2008-02-07 |
| PL1691827T3 (pl) | 2010-01-29 |
| AU2005256121A8 (en) | 2008-08-21 |
| AU2005256121B2 (en) | 2011-03-03 |
| EA008799B1 (ru) | 2007-08-31 |
| CA2544676A1 (en) | 2006-01-05 |
| IL173969A (en) | 2011-06-30 |
| NZ545634A (en) | 2009-09-25 |
| ATE439856T1 (de) | 2009-09-15 |
| HK1093308A1 (zh) | 2007-03-02 |
| EA200600561A1 (ru) | 2006-08-25 |
| US20080249006A1 (en) | 2008-10-09 |
| CY1109631T1 (el) | 2014-08-13 |
| SI1691827T1 (sl) | 2010-01-29 |
| DK1691827T3 (da) | 2009-12-14 |
| WO2006000007A1 (de) | 2006-01-05 |
| DE502005007926D1 (de) | 2009-10-01 |
| ES2331958T3 (es) | 2010-01-21 |
| AU2005256121A1 (en) | 2006-04-27 |
| HRP20090618T1 (hr) | 2010-01-31 |
| EP1691827A1 (de) | 2006-08-23 |
| EP1691827B1 (de) | 2009-08-19 |
| PT1691827E (pt) | 2009-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109631T1 (el) | Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ | |
| WO2009004315A8 (en) | Isolated peptides and uses thereof | |
| ATE451390T1 (de) | Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys) | |
| NZ593815A (en) | Tissue factor pathway inhibitor (tfpi) inhibitors and methods of use | |
| DK2231860T3 (da) | Polypeptid afledt protein A og i stand til at binde PDGF | |
| WO2006113681A3 (en) | Plant-derived elastin binding protein ligands and methods of using the same | |
| MX2009000656A (es) | Acidos nucleicos que se fijan a sdf-i. | |
| DE602005020165D1 (de) | Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin | |
| DE60233532D1 (de) | An proteinphosphatase 2a bindende synthetische ode anwendungen | |
| MX2008009493A (es) | Peptido novedoso y uso del mismo. | |
| WO2008003707A3 (en) | Minimized small peptides with high affinity for factor viii and factor viii-like proteins | |
| DE60034888D1 (de) | N-substituierte l-aminosäuren enthaltende peptide, zur prävention der beta-strang assoziation | |
| UA91497C2 (ru) | ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА | |
| ATE538806T1 (de) | Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren | |
| WO2007066018A3 (fr) | Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques | |
| ATE485831T1 (de) | Behandlung von neurodegeneration | |
| DE60120187D1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen | |
| WO2008068765A3 (en) | Compositions and methods for inhibiting hiv-1 replication and integrase activity | |
| GB0426960D0 (en) | TGR-3 like protein receptor | |
| CY1110650T1 (el) | Πεπτιδια τα οποια συνδεουν την πρωτεϊνικη φωσφαταση 2α και πολυνουκλεοτιδια που τα κωδικοποιουν | |
| WO2005087809B1 (en) | Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion | |
| WO2007020405A3 (en) | Integrin i-domain binding peptides | |
| ATE397657T1 (de) | An die lck-sh3 und hck-sh3 domäne bindendes peptid | |
| NZ591989A (en) | Prion-specific peptide reagents | |
| ATE491947T1 (de) | Peptid zur hemmung von calcineurin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DA 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2208 DE 30/04/2013. |